IPP Bureau
Kwality Pharmaceuticals concludes regulatory audit for Zimbabwe
By IPP Bureau - May 12, 2025
This marks yet another milestone in our series of successful audits over the past year
Poly Medicure posts Q4 FY25 consolidated profit at Rs. 91.83 Cr
By IPP Bureau - May 12, 2025
The company has posted net profit of Rs. 338.55 crores for the Financial Year ended March 31, 2025
Dabur India posts Q4 FY25 consolidated PAT at Rs. 320.13 Cr
By IPP Bureau - May 12, 2025
The company has posted net profit of Rs. 1,767.63 crores for the Financial Year ended March 31, 2025
Jagsonpal Pharmaceuticals posts Q4 FY25 PAT at Rs. 6.58 Cr
By IPP Bureau - May 12, 2025
The company has posted net profit of Rs. 55.36 crores for the Financial Year ended March 31, 2025
Indian School of Public Policy and Indegene announce strategic collaboration
By IPP Bureau - May 12, 2025
ISPP will analyze health systems across states, identifying scalable models and actionable insights to strengthen India's healthcare delivery
Aarti Drugs Ltd Q4 FY2025 consolidated PAT climbs to Rs. 62.86 Cr
By IPP Bureau - May 12, 2025
The company has posted net profit of Rs.168.16 crores for the Financial Year ended March 31, 2025
Zydus receives final approval from USFDA for Glatiramer Acetate Injection
By IPP Bureau - May 12, 2025
Glatiramer Acetate is the generic version of Copaxone 20 mg/ml, 40 mg/ml, Single-Dose Prefilled Syringes
Agilent inaugurates India Solution Center to accelerate innovation
By IPP Bureau - May 09, 2025
Integrated facility to deliver end-to-end, customized workflows across life sciences, diagnostics, and applied markets
Lupin launches Eslicarbazepine Acetate tablets in US
By IPP Bureau - May 08, 2025
Lupin is one of the first ANDA applicants and is eligible for 180 days of shared generic exclusivity
Sigachi Industries receives CEP for Metformin Hydrochloride from EDQM
By IPP Bureau - May 08, 2025
The CEP certification for Metformin Hydrochloride aligns with the company's strategy to penetrate stringently regulated markets
Suven Pharmaceuticals is now Cohance Lifesciences
By IPP Bureau - May 08, 2025
The change of name has been carried on pursuant to the Scheme of Amalgamation
Granules India bags EcoVadis’ Gold Rating
By IPP Bureau - May 08, 2025
The company's first-ever corporate-level submission to EcoVadis builds on years of operational and environmental excellence
AstraZeneca's enhertu improved pCR in early-stage breast cancer
By IPP Bureau - May 07, 2025
AstraZeneca and Daiichi Sankyo’s Enhertu followed by THP showed an improved safety profile vs. standard of care
Europe (AGES, Austria) inspects Shilpa Biologicals’ Dharwad site
By IPP Bureau - May 06, 2025
he inspection covering the sterile drug product filling and packaging line, quality systems and quality control laboratories concluded compliance with the principles and guidelines of Good Manufacturing Practice
Briefs: Tatva Chintan Pharma Chem and Shelter Pharma
By IPP Bureau - May 06, 2025
Tatva Chintan Pharma Chem receives export order worth $35, 55,000
